RESELIGO
3,6MG IMP ISP 1
Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
---|---|---|---|---|
Cessation of marketing | 18.01.2021 |
0246044 |
Transfer of marketing authorisation | |
Placing on the market | 01.12.2016 |
All reports are available in the Overview.